日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer

ROS1 融合阳性肺癌对克唑替尼和劳拉替尼的耐药机制

Jessica J Lin #, Noura J Choudhury #, Satoshi Yoda #, Viola W Zhu, Ted W Johnson, Ramin Sakhtemani, Ibiayi Dagogo-Jack, Subba R Digumarthy, Charlotte Lee, Andrew Do, Jennifer Peterson, Kylie Prutisto-Chang, Wafa Malik, Harper G Hubbeling, Adam Langenbucher, Adam J Schoenfeld, Christina J Falcon, Jen

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

奥拉帕尼与替莫唑胺联合治疗复发性小细胞肺癌

Anna F Farago, Beow Y Yeap, Marcello Stanzione, Yin P Hung, Rebecca S Heist, J Paul Marcoux, Jun Zhong, Deepa Rangachari, David A Barbie, Sarah Phat, David T Myers, Robert Morris, Marina Kem, Taronish D Dubash, Elizabeth A Kennedy, Subba R Digumarthy, Lecia V Sequist, Aaron N Hata, Shyamala Maheswar

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors

未接受治疗的癌症中的 BIM 表达可预测对激酶抑制剂的反应性

Anthony C Faber, Ryan B Corcoran, Hiromichi Ebi, Lecia V Sequist, Belinda A Waltman, Euiheon Chung, Joao Incio, Subba R Digumarthy, Sarah F Pollack, Youngchul Song, Alona Muzikansky, Eugene Lifshits, Sylvie Roberge, Erik J Coffman, Cyril H Benes, Henry L Gómez, José Baselga, Carlos L Arteaga, Miguel